0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neonatal Genetic Disease Diagnosis Market Research Report 2026
Published Date: 2026-02-26
|
Report Code: QYRE-Auto-16F18110
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Neonatal Genetic Disease Diagnosis Market Research Report 2024
BUY CHAPTERS

Global Neonatal Genetic Disease Diagnosis Market Research Report 2026

Code: QYRE-Auto-16F18110
Report
2026-02-26
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Neonatal Genetic Disease Diagnosis Market

The global Neonatal Genetic Disease Diagnosis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Neonatal genetic disease diagnosis refers to the process of identifying genetic disorders in newborns, typically through a combination of genetic testing, clinical evaluation, and family history analysis. This diagnostic process is crucial for early detection and management of genetic conditions, which can significantly impact a child's health and development.
The North American market for Neonatal Genetic Disease Diagnosis is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Neonatal Genetic Disease Diagnosis is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Neonatal Genetic Disease Diagnosis in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Neonatal Genetic Disease Diagnosis include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd., Illumina, CapitalBio Technology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Neonatal Genetic Disease Diagnosis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neonatal Genetic Disease Diagnosis. The Neonatal Genetic Disease Diagnosis market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Neonatal Genetic Disease Diagnosis market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Neonatal Genetic Disease Diagnosis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Neonatal Genetic Disease Diagnosis Market Report

Report Metric Details
Report Name Neonatal Genetic Disease Diagnosis Market
Segment by Type
  • Prenatal Diagnosis
  • Screening for Single Gene Genetic Disease
  • Preimplantation Genetic Testing
  • Others
Segment by Application
  • Hospital
  • Medical Laboratory
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd., Illumina, CapitalBio Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Neonatal Genetic Disease Diagnosis companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Neonatal Genetic Disease Diagnosis Market report?

Ans: The main players in the Neonatal Genetic Disease Diagnosis Market are Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd., Illumina, CapitalBio Technology

What are the Application segmentation covered in the Neonatal Genetic Disease Diagnosis Market report?

Ans: The Applications covered in the Neonatal Genetic Disease Diagnosis Market report are Hospital, Medical Laboratory, Others

What are the Type segmentation covered in the Neonatal Genetic Disease Diagnosis Market report?

Ans: The Types covered in the Neonatal Genetic Disease Diagnosis Market report are Prenatal Diagnosis, Screening for Single Gene Genetic Disease, Preimplantation Genetic Testing, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Prenatal Diagnosis
1.2.3 Screening for Single Gene Genetic Disease
1.2.4 Preimplantation Genetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Neonatal Genetic Disease Diagnosis Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Medical Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neonatal Genetic Disease Diagnosis Market Perspective (2021–2032)
2.2 Global Neonatal Genetic Disease Diagnosis Growth Trends by Region
2.2.1 Global Neonatal Genetic Disease Diagnosis Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Neonatal Genetic Disease Diagnosis Historic Market Size by Region (2021–2026)
2.2.3 Neonatal Genetic Disease Diagnosis Forecasted Market Size by Region (2027–2032)
2.3 Neonatal Genetic Disease Diagnosis Market Dynamics
2.3.1 Neonatal Genetic Disease Diagnosis Industry Trends
2.3.2 Neonatal Genetic Disease Diagnosis Market Drivers
2.3.3 Neonatal Genetic Disease Diagnosis Market Challenges
2.3.4 Neonatal Genetic Disease Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neonatal Genetic Disease Diagnosis Players by Revenue
3.1.1 Global Top Neonatal Genetic Disease Diagnosis Players by Revenue (2021–2026)
3.1.2 Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Players (2021–2026)
3.2 Global Top Neonatal Genetic Disease Diagnosis Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Neonatal Genetic Disease Diagnosis Revenue
3.4 Global Neonatal Genetic Disease Diagnosis Market Concentration Ratio
3.4.1 Global Neonatal Genetic Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neonatal Genetic Disease Diagnosis Revenue in 2025
3.5 Global Key Players of Neonatal Genetic Disease Diagnosis Head Offices and Areas Served
3.6 Global Key Players of Neonatal Genetic Disease Diagnosis, Products and Applications
3.7 Global Key Players of Neonatal Genetic Disease Diagnosis, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Neonatal Genetic Disease Diagnosis Breakdown Data by Type
4.1 Global Neonatal Genetic Disease Diagnosis Historic Market Size by Type (2021–2026)
4.2 Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Type (2027–2032)
5 Neonatal Genetic Disease Diagnosis Breakdown Data by Application
5.1 Global Neonatal Genetic Disease Diagnosis Historic Market Size by Application (2021–2026)
5.2 Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Neonatal Genetic Disease Diagnosis Market Size (2021–2032)
6.2 North America Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Neonatal Genetic Disease Diagnosis Market Size by Country (2021–2026)
6.4 North America Neonatal Genetic Disease Diagnosis Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neonatal Genetic Disease Diagnosis Market Size (2021–2032)
7.2 Europe Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2021–2026)
7.4 Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size (2021–2032)
8.2 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Region (2021–2026)
8.4 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Neonatal Genetic Disease Diagnosis Market Size (2021–2032)
9.2 Latin America Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Neonatal Genetic Disease Diagnosis Market Size by Country (2021–2026)
9.4 Latin America Neonatal Genetic Disease Diagnosis Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size (2021–2032)
10.2 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2021–2026)
10.4 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Neonatal Genetic Disease Diagnosis Introduction
11.1.4 Abbott Revenue in Neonatal Genetic Disease Diagnosis Business (2021–2026)
11.1.5 Abbott Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Neonatal Genetic Disease Diagnosis Introduction
11.2.4 PerkinElmer Revenue in Neonatal Genetic Disease Diagnosis Business (2021–2026)
11.2.5 PerkinElmer Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Details
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Neonatal Genetic Disease Diagnosis Introduction
11.3.4 Roche Diagnostics Revenue in Neonatal Genetic Disease Diagnosis Business (2021–2026)
11.3.5 Roche Diagnostics Recent Development
11.4 Bio Rad
11.4.1 Bio Rad Company Details
11.4.2 Bio Rad Business Overview
11.4.3 Bio Rad Neonatal Genetic Disease Diagnosis Introduction
11.4.4 Bio Rad Revenue in Neonatal Genetic Disease Diagnosis Business (2021–2026)
11.4.5 Bio Rad Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Neonatal Genetic Disease Diagnosis Introduction
11.5.4 Thermo Fisher Scientific Revenue in Neonatal Genetic Disease Diagnosis Business (2021–2026)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 BGI Group
11.6.1 BGI Group Company Details
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Neonatal Genetic Disease Diagnosis Introduction
11.6.4 BGI Group Revenue in Neonatal Genetic Disease Diagnosis Business (2021–2026)
11.6.5 BGI Group Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Neonatal Genetic Disease Diagnosis Introduction
11.7.4 Berry Genomics Revenue in Neonatal Genetic Disease Diagnosis Business (2021–2026)
11.7.5 Berry Genomics Recent Development
11.8 Da An Gene Co., Ltd.
11.8.1 Da An Gene Co., Ltd. Company Details
11.8.2 Da An Gene Co., Ltd. Business Overview
11.8.3 Da An Gene Co., Ltd. Neonatal Genetic Disease Diagnosis Introduction
11.8.4 Da An Gene Co., Ltd. Revenue in Neonatal Genetic Disease Diagnosis Business (2021–2026)
11.8.5 Da An Gene Co., Ltd. Recent Development
11.9 Illumina
11.9.1 Illumina Company Details
11.9.2 Illumina Business Overview
11.9.3 Illumina Neonatal Genetic Disease Diagnosis Introduction
11.9.4 Illumina Revenue in Neonatal Genetic Disease Diagnosis Business (2021–2026)
11.9.5 Illumina Recent Development
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Company Details
11.10.2 CapitalBio Technology Business Overview
11.10.3 CapitalBio Technology Neonatal Genetic Disease Diagnosis Introduction
11.10.4 CapitalBio Technology Revenue in Neonatal Genetic Disease Diagnosis Business (2021–2026)
11.10.5 CapitalBio Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Prenatal Diagnosis
 Table 3. Key Players of Screening for Single Gene Genetic Disease
 Table 4. Key Players of Preimplantation Genetic Testing
 Table 5. Key Players of Others
 Table 6. Global Neonatal Genetic Disease Diagnosis Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Neonatal Genetic Disease Diagnosis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Neonatal Genetic Disease Diagnosis Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Neonatal Genetic Disease Diagnosis Market Share by Region (2021–2026)
 Table 10. Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Neonatal Genetic Disease Diagnosis Market Share by Region (2027–2032)
 Table 12. Neonatal Genetic Disease Diagnosis Market Trends
 Table 13. Neonatal Genetic Disease Diagnosis Market Drivers
 Table 14. Neonatal Genetic Disease Diagnosis Market Challenges
 Table 15. Neonatal Genetic Disease Diagnosis Market Restraints
 Table 16. Global Neonatal Genetic Disease Diagnosis Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Neonatal Genetic Disease Diagnosis Market Share by Players (2021–2026)
 Table 18. Global Top Neonatal Genetic Disease Diagnosis Players by Tier (Tier 1, Tier 2, and Tier 3), based on Neonatal Genetic Disease Diagnosis Revenue, 2025
 Table 19. Ranking of Global Top Neonatal Genetic Disease Diagnosis Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Neonatal Genetic Disease Diagnosis Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Neonatal Genetic Disease Diagnosis, Headquarters and Area Served
 Table 22. Global Key Players of Neonatal Genetic Disease Diagnosis, Products and Applications
 Table 23. Global Key Players of Neonatal Genetic Disease Diagnosis, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Neonatal Genetic Disease Diagnosis Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Type (2021–2026)
 Table 27. Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Type (2027–2032)
 Table 29. Global Neonatal Genetic Disease Diagnosis Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Application (2021–2026)
 Table 31. Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Application (2027–2032)
 Table 33. North America Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Neonatal Genetic Disease Diagnosis Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Neonatal Genetic Disease Diagnosis Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Neonatal Genetic Disease Diagnosis Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Neonatal Genetic Disease Diagnosis Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Neonatal Genetic Disease Diagnosis Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Neonatal Genetic Disease Diagnosis Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (US$ Million), 2027–2032
 Table 48. Abbott Company Details
 Table 49. Abbott Business Overview
 Table 50. Abbott Neonatal Genetic Disease Diagnosis Product
 Table 51. Abbott Revenue in Neonatal Genetic Disease Diagnosis Business (US$ Million), 2021–2026
 Table 52. Abbott Recent Development
 Table 53. PerkinElmer Company Details
 Table 54. PerkinElmer Business Overview
 Table 55. PerkinElmer Neonatal Genetic Disease Diagnosis Product
 Table 56. PerkinElmer Revenue in Neonatal Genetic Disease Diagnosis Business (US$ Million), 2021–2026
 Table 57. PerkinElmer Recent Development
 Table 58. Roche Diagnostics Company Details
 Table 59. Roche Diagnostics Business Overview
 Table 60. Roche Diagnostics Neonatal Genetic Disease Diagnosis Product
 Table 61. Roche Diagnostics Revenue in Neonatal Genetic Disease Diagnosis Business (US$ Million), 2021–2026
 Table 62. Roche Diagnostics Recent Development
 Table 63. Bio Rad Company Details
 Table 64. Bio Rad Business Overview
 Table 65. Bio Rad Neonatal Genetic Disease Diagnosis Product
 Table 66. Bio Rad Revenue in Neonatal Genetic Disease Diagnosis Business (US$ Million), 2021–2026
 Table 67. Bio Rad Recent Development
 Table 68. Thermo Fisher Scientific Company Details
 Table 69. Thermo Fisher Scientific Business Overview
 Table 70. Thermo Fisher Scientific Neonatal Genetic Disease Diagnosis Product
 Table 71. Thermo Fisher Scientific Revenue in Neonatal Genetic Disease Diagnosis Business (US$ Million), 2021–2026
 Table 72. Thermo Fisher Scientific Recent Development
 Table 73. BGI Group Company Details
 Table 74. BGI Group Business Overview
 Table 75. BGI Group Neonatal Genetic Disease Diagnosis Product
 Table 76. BGI Group Revenue in Neonatal Genetic Disease Diagnosis Business (US$ Million), 2021–2026
 Table 77. BGI Group Recent Development
 Table 78. Berry Genomics Company Details
 Table 79. Berry Genomics Business Overview
 Table 80. Berry Genomics Neonatal Genetic Disease Diagnosis Product
 Table 81. Berry Genomics Revenue in Neonatal Genetic Disease Diagnosis Business (US$ Million), 2021–2026
 Table 82. Berry Genomics Recent Development
 Table 83. Da An Gene Co., Ltd. Company Details
 Table 84. Da An Gene Co., Ltd. Business Overview
 Table 85. Da An Gene Co., Ltd. Neonatal Genetic Disease Diagnosis Product
 Table 86. Da An Gene Co., Ltd. Revenue in Neonatal Genetic Disease Diagnosis Business (US$ Million), 2021–2026
 Table 87. Da An Gene Co., Ltd. Recent Development
 Table 88. Illumina Company Details
 Table 89. Illumina Business Overview
 Table 90. Illumina Neonatal Genetic Disease Diagnosis Product
 Table 91. Illumina Revenue in Neonatal Genetic Disease Diagnosis Business (US$ Million), 2021–2026
 Table 92. Illumina Recent Development
 Table 93. CapitalBio Technology Company Details
 Table 94. CapitalBio Technology Business Overview
 Table 95. CapitalBio Technology Neonatal Genetic Disease Diagnosis Product
 Table 96. CapitalBio Technology Revenue in Neonatal Genetic Disease Diagnosis Business (US$ Million), 2021–2026
 Table 97. CapitalBio Technology Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Neonatal Genetic Disease Diagnosis Picture
 Figure 2. Global Neonatal Genetic Disease Diagnosis Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Neonatal Genetic Disease Diagnosis Market Share by Type: 2025 vs 2032
 Figure 4. Prenatal Diagnosis Features
 Figure 5. Screening for Single Gene Genetic Disease Features
 Figure 6. Preimplantation Genetic Testing Features
 Figure 7. Others Features
 Figure 8. Global Neonatal Genetic Disease Diagnosis Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Neonatal Genetic Disease Diagnosis Market Share by Application: 2025 vs 2032
 Figure 10. Hospital Case Studies
 Figure 11. Medical Laboratory Case Studies
 Figure 12. Others Case Studies
 Figure 13. Neonatal Genetic Disease Diagnosis Report Years Considered
 Figure 14. Global Neonatal Genetic Disease Diagnosis Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Neonatal Genetic Disease Diagnosis Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Neonatal Genetic Disease Diagnosis Market Share by Region: 2025 vs 2032
 Figure 17. Global Neonatal Genetic Disease Diagnosis Market Share by Players in 2025
 Figure 18. Global Neonatal Genetic Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Neonatal Genetic Disease Diagnosis Revenue in 2025
 Figure 20. North America Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Neonatal Genetic Disease Diagnosis Market Share by Country (2021–2032)
 Figure 22. United States Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Neonatal Genetic Disease Diagnosis Market Share by Country (2021–2032)
 Figure 26. Germany Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Share by Region (2021–2032)
 Figure 34. China Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Neonatal Genetic Disease Diagnosis Market Share by Country (2021–2032)
 Figure 42. Mexico Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Neonatal Genetic Disease Diagnosis Market Share by Country (2021–2032)
 Figure 46. Israel Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Neonatal Genetic Disease Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Abbott Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2021–2026)
 Figure 50. PerkinElmer Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2021–2026)
 Figure 51. Roche Diagnostics Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2021–2026)
 Figure 52. Bio Rad Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2021–2026)
 Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2021–2026)
 Figure 54. BGI Group Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2021–2026)
 Figure 55. Berry Genomics Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2021–2026)
 Figure 56. Da An Gene Co., Ltd. Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2021–2026)
 Figure 57. Illumina Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2021–2026)
 Figure 58. CapitalBio Technology Revenue Growth Rate in Neonatal Genetic Disease Diagnosis Business (2021–2026)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS